On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells.

Glioblastoma Gliomagenesis Mesenchymal stromal cells Microenvironment Neural crest Pericytes Perivascular fibroblasts

Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
24 06 2023
Historique:
received: 11 04 2023
accepted: 18 06 2023
medline: 26 6 2023
pubmed: 25 6 2023
entrez: 24 6 2023
Statut: epublish

Résumé

Glioblastoma, IDH wild-type is the most common and aggressive form of glial tumors. The exact mechanisms of glioblastoma oncogenesis, including the identification of the glioma-initiating cell, are yet to be discovered. Recent studies have led to the hypothesis that glioblastoma arises from neural stem cells and glial precursor cells and that cell lineage constitutes a key determinant of the glioblastoma molecular subtype. These findings brought significant advancement to the comprehension of gliomagenesis. However, the cellular origin of glioblastoma with mesenchymal molecular features remains elusive. Mesenchymal stromal cells emerge as potential glioblastoma-initiating cells, especially with regard to the mesenchymal molecular subtype. These fibroblast-like cells, which derive from the neural crest and reside in the perivascular niche, may underlie gliomagenesis and exert pro-tumoral effects within the tumor microenvironment. This review synthesizes the potential roles of mesenchymal stromal cells in the context of glioblastoma and provides novel research avenues to better understand this lethal disease.

Identifiants

pubmed: 37355636
doi: 10.1186/s40478-023-01605-x
pii: 10.1186/s40478-023-01605-x
pmc: PMC10290416
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Subventions

Organisme : Conseil Régional de La Réunion
ID : 2017-1198-0002583
Organisme : Conseil Régional de La Réunion
ID : 2019-2211-0022768

Informations de copyright

© 2023. The Author(s).

Références

Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2199-204
pubmed: 11854516
Cell Stem Cell. 2020 Jan 2;26(1):48-63.e6
pubmed: 31901251
Nature. 2006 Dec 7;444(7120):756-60
pubmed: 17051156
Immunology. 2018 Nov;155(3):346-355
pubmed: 29923617
J Neuroimmune Pharmacol. 2020 Dec;15(4):838-851
pubmed: 32964324
J Immunol. 2012 Jul 1;189(1):444-53
pubmed: 22664874
Nature. 2018 Feb 22;554(7693):475-480
pubmed: 29443965
J Cereb Blood Flow Metab. 2013 Mar;33(3):428-39
pubmed: 23250106
J Cell Sci. 2004 Sep 1;117(Pt 19):4411-22
pubmed: 15304527
Science. 2012 Nov 23;338(6110):1080-4
pubmed: 23087000
PLoS One. 2012;7(4):e35577
pubmed: 22523602
Science. 2012 Sep 7;337(6099):1231-5
pubmed: 22837387
Nature. 2012 Aug 23;488(7412):522-6
pubmed: 22854781
Oncotarget. 2019 Jan 29;10(9):993-1009
pubmed: 30847027
J Neurooncol. 2017 Jan;131(2):245-254
pubmed: 27757723
Nat Neurosci. 2021 Feb;24(2):234-244
pubmed: 33526922
Nat Rev Neurosci. 2022 Jan;23(1):23-34
pubmed: 34671105
Nature. 2022 Mar;603(7903):893-899
pubmed: 35158371
Brain. 2019 Dec 1;142(12):3834-3851
pubmed: 31665239
J Vasc Res. 1999 Jan-Feb;36(1):2-27
pubmed: 10050070
PLoS Genet. 2020 Oct 26;16(10):e1008800
pubmed: 33104690
Int J Oncol. 2013 May;42(5):1754-62
pubmed: 23483121
J Neurooncol. 2007 Jul;83(3):241-7
pubmed: 17570034
Acta Neuropathol Commun. 2020 Dec 11;8(1):221
pubmed: 33308315
J Neurosci. 2012 Sep 12;32(37):12950-60
pubmed: 22973019
Clin Pharmacol Ther. 2007 Sep;82(3):241-3
pubmed: 17700588
Brain Res. 2004 Jun 4;1010(1-2):108-16
pubmed: 15126123
Acta Neuropathol Commun. 2021 Mar 25;9(1):54
pubmed: 33766119
CA Cancer J Clin. 2020 Jul;70(4):299-312
pubmed: 32478924
Annu Rev Pathol. 2011;6:457-78
pubmed: 21073342
Cell Stem Cell. 2011 Jul 8;9(1):11-5
pubmed: 21726829
Blood. 2007 Nov 15;110(10):3499-506
pubmed: 17664353
Cancer Cell. 2010 May 18;17(5):510-22
pubmed: 20399149
Cell. 2018 Aug 9;174(4):1015-1030.e16
pubmed: 30096299
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
J Neuroimmunol. 2014 Sep 15;274(1-2):71-7
pubmed: 25042352
Oncotarget. 2015 Jun 20;6(17):15077-94
pubmed: 25987130
Brain. 2019 Apr 1;142(4):847-866
pubmed: 30946477
Cell. 2018 Aug 9;174(4):999-1014.e22
pubmed: 30096314
Development. 2004 Oct;131(19):4637-50
pubmed: 15358668
Am J Pathol. 1995 Jul;147(1):53-67
pubmed: 7604885
Mol Med. 2012 May 09;18:519-27
pubmed: 22294205
Blood. 2005 Sep 1;106(5):1755-61
pubmed: 15905186
Oncotarget. 2016 Jun 14;7(24):36021-36033
pubmed: 27074570
Neuro Oncol. 2017 May 1;19(5):660-668
pubmed: 28453745
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23714-23723
pubmed: 31712430
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Neuron. 2019 Nov 6;104(3):442-449
pubmed: 31697921
Stem Cells. 2015 Aug;33(8):2400-15
pubmed: 25966666
Cell Physiol Biochem. 2018;46(1):279-290
pubmed: 29590646
Cancer Cell. 2017 Jul 10;32(1):42-56.e6
pubmed: 28697342
Nat Rev Cancer. 2014 Feb;14(2):92-107
pubmed: 24457416
Nat Rev Immunol. 2018 Nov;18(11):689-702
pubmed: 30127389
Int J Mol Sci. 2022 Jul 21;23(14):
pubmed: 35887383
J Neuropathol Exp Neurol. 2015 May;74(5):390-400
pubmed: 25853692
Exp Hematol. 2000 Aug;28(8):875-84
pubmed: 10989188
Glia. 1991;4(3):314-21
pubmed: 1832659
Nature. 2006 Oct 12;443(7112):700-4
pubmed: 17036005
Nat Rev Immunol. 2015 Nov;15(11):669-82
pubmed: 26471778
J Neurooncol. 2011 Oct;105(1):57-65
pubmed: 21547397
Annu Rev Pathol. 2013 Jan 24;8:241-76
pubmed: 23092186
Cancer Cell. 2007 Jan;11(1):69-82
pubmed: 17222791
Cancer Cell. 2009 Jan 6;15(1):45-56
pubmed: 19111880
Nat Rev Neurol. 2018 Aug;14(8):482-495
pubmed: 29985475
Nature. 2004 Nov 18;432(7015):396-401
pubmed: 15549107
Brain Pathol. 2014 Jul;24(4):404-13
pubmed: 24946078
Oncotarget. 2017 Aug 2;8(40):68614-68626
pubmed: 28978142
Acta Neuropathol. 2003 Apr;105(4):328-32
pubmed: 12624785
Stem Cells. 2014 May;32(5):1110-23
pubmed: 24302539
Int J Mol Sci. 2014 Apr 16;15(4):6453-74
pubmed: 24743889
Nature. 2014 Apr 3;508(7494):55-60
pubmed: 24670647
Oncogene. 2017 Jan 26;36(4):570-584
pubmed: 27345406
Angiogenesis. 2020 Feb;23(1):9-16
pubmed: 31679081
Cancer Cell. 2012 Oct 16;22(4):425-37
pubmed: 23079654
J Orthop Res. 1991 Sep;9(5):641-50
pubmed: 1870029
Lancet. 2008 May 10;371(9624):1579-86
pubmed: 18468541
Cell. 2007 Jun 29;129(7):1377-88
pubmed: 17604725
Nature. 2010 Dec 9;468(7325):824-8
pubmed: 21102434
Dev Cell. 2011 Aug 16;21(2):193-215
pubmed: 21839917
Stem Cells. 2010 Feb;28(2):181-90
pubmed: 19937755
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Signal Transduct Target Ther. 2018 Feb 9;3:4
pubmed: 29527330
Nat Rev Neurosci. 2004 Feb;5(2):146-56
pubmed: 14735117
Nat Med. 2001 Nov;7(11):1194-201
pubmed: 11689883
Acta Histochem. 2013 Oct;115(8):865-78
pubmed: 23701962
Cancer Cell. 2013 Sep 9;24(3):331-46
pubmed: 23993863
Genes Dev. 1998 Dec 1;12(23):3675-85
pubmed: 9851974
Cell Stem Cell. 2008 Sep 11;3(3):301-13
pubmed: 18786417
Cancer Res. 2016 Oct 1;76(19):5671-5682
pubmed: 27530322
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Biomarkers. 2019 Nov;24(7):677-683
pubmed: 31496301
Cell. 2020 Jun 25;181(7):1643-1660.e17
pubmed: 32470396
Exp Hematol. 2002 Jan;30(1):42-8
pubmed: 11823036
Immunity. 2010 May 28;32(5):593-604
pubmed: 20510870
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Mol Ther. 2009 Jun;17(6):939-46
pubmed: 19337235
JCI Insight. 2016;1(2):
pubmed: 26973881
Nat Neurosci. 2019 Apr;22(4):545-555
pubmed: 30778149
Lancet Neurol. 2002 Jun;1(2):92-100
pubmed: 12849513
Oncotarget. 2012 Jan;3(1):98-106
pubmed: 22298889
Neuro Oncol. 2014 Jul;16(7):896-913
pubmed: 24842956
Nat Neurosci. 2011 Oct 26;14(11):1382-9
pubmed: 22030549
Cell. 2011 Jul 22;146(2):209-21
pubmed: 21737130
PLoS One. 2012;7(8):e43339
pubmed: 22937035
Cell. 2013 Mar 28;153(1):139-52
pubmed: 23540695
Exp Hematol. 2008 May;36(5):642-54
pubmed: 18295964
Cell. 2019 Aug 8;178(4):835-849.e21
pubmed: 31327527
Int J Mol Sci. 2023 May 31;24(11):
pubmed: 37298499
Histol Histopathol. 2009 Jul;24(7):909-69
pubmed: 19475537
Blood. 2005 Feb 1;105(3):1094-101
pubmed: 15459006
Cell. 2019 Jun 27;178(1):160-175.e27
pubmed: 31155233
J Neuroinflammation. 2014 Jun 11;11:104
pubmed: 24920309
Exp Neurol. 2002 Mar;174(1):11-20
pubmed: 11869029
Neuropathol Appl Neurobiol. 2018 Feb;44(2):185-206
pubmed: 28767130
Brain Tumor Pathol. 2012 Jul;29(3):160-7
pubmed: 22350668
Cancers (Basel). 2023 May 07;15(9):
pubmed: 37174113
Neuro Oncol. 2005 Oct;7(4):452-64
pubmed: 16212810
J Neuropathol Exp Neurol. 2004 Dec;63(12):1274-83
pubmed: 15624764
Neuro Oncol. 2002 Oct;4(4):278-99
pubmed: 12356358
Stem Cells. 2008 Sep;26(9):2287-99
pubmed: 18566331
Nature. 2018 Aug;560(7717):243-247
pubmed: 30069053
N Engl J Med. 2005 Aug 25;353(8):811-22
pubmed: 16120861
Cancer Immunol Res. 2013 Aug;1(2):112-22
pubmed: 24409449
Cell Stem Cell. 2017 Aug 3;21(2):166-177
pubmed: 28777943
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Oncotarget. 2018 May 15;9(37):24766-24777
pubmed: 29872504
J Neurosci. 2013 Aug 21;33(34):13882-7
pubmed: 23966707
Oncoimmunology. 2019 Aug 22;8(11):e1655360
pubmed: 31646100
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4274-80
pubmed: 21262804
Cytotherapy. 2012 Nov;14(10):1203-14
pubmed: 22909277
J Neurosci. 1999 Dec 15;19(24):10778-88
pubmed: 10594061
Cancer Cell. 2006 Mar;9(3):157-73
pubmed: 16530701
J Pathol. 2014 May;233(1):74-88
pubmed: 24481573
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2088-93
pubmed: 12576546
Oncotarget. 2017 Apr 11;8(15):25482-25499
pubmed: 28424417
Cancer Cell. 2020 Sep 14;38(3):366-379.e8
pubmed: 32649888
Exp Cell Res. 2021 May 15;402(2):112576
pubmed: 33798592
Cell Rep. 2016 Nov 22;17(9):2445-2459
pubmed: 27840052
Nat Neurosci. 2019 Jun;22(6):1021-1035
pubmed: 31061494
Cell Death Differ. 2008 Sep;15(9):1491-8
pubmed: 18497759
Sci Rep. 2020 Nov 11;10(1):19542
pubmed: 33177572
Brain. 2010 Apr;133(Pt 4):973-82
pubmed: 20375132
Sci Adv. 2022 Jun 10;8(23):eabm6340
pubmed: 35675414
J Cell Sci. 2006 Jun 1;119(Pt 11):2204-13
pubmed: 16684817
Exp Neurol. 2004 Jun;187(2):319-28
pubmed: 15144858
Genome Biol. 2017 Dec 20;18(1):234
pubmed: 29262845
Science. 2011 Jul 8;333(6039):238-42
pubmed: 21737741
Cancer Res. 2017 May 1;77(9):2266-2278
pubmed: 28235764
Cell Stem Cell. 2008 Sep 11;3(3):229-30
pubmed: 18786406
Cell Stem Cell. 2008 Sep 11;3(3):279-88
pubmed: 18786415
Transplantation. 1974 Apr;17(4):331-40
pubmed: 4150881
Int J Mol Sci. 2022 Aug 17;23(16):
pubmed: 36012544
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1248-58
pubmed: 17379839
Cell Death Dis. 2018 Oct 27;9(11):1101
pubmed: 30368520
J Neuroinflammation. 2011 Oct 13;8:139
pubmed: 21995440
Front Immunol. 2013 Sep 04;4:201
pubmed: 24027567
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105
pubmed: 34608945

Auteurs

F Ah-Pine (F)

Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, 97400, Saint-Denis, France. franck.ah-pine@chu-reunion.fr.
Service d'Anatomie et Cytologie Pathologiques, CHU de La Réunion sites SUD - Saint-Pierre, BP 350, 97448, Saint-Pierre Cedex, France. franck.ah-pine@chu-reunion.fr.

M Khettab (M)

Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, 97400, Saint-Denis, France.
Service d'Oncologie Médicale, CHU de La Réunion sites SUD - Saint-Pierre, BP 350, 97448, Saint-Pierre Cedex, France.

Y Bedoui (Y)

Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, 97400, Saint-Denis, France.
Service d'Anatomie et Cytologie Pathologiques, CHU de La Réunion sites SUD - Saint-Pierre, BP 350, 97448, Saint-Pierre Cedex, France.

Y Slama (Y)

Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, 97400, Saint-Denis, France.

M Daniel (M)

Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, 97400, Saint-Denis, France.
Service de Médecine d'Urgences-SAMU-SMUR, CHU de La Réunion - Site Félix Guyon, Allée Des Topazes CS 11 021, 97400, Saint-Denis, France.

B Doray (B)

Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, 97400, Saint-Denis, France.
Service de Génétique, CHU de La Réunion - Site Félix Guyon, Allée Des Topazes CS 11 021, 97400, Saint-Denis, France.

P Gasque (P)

Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, 97400, Saint-Denis, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH